Home›Search›Hematology/ Oncology and Stem Cell Therapy

Hematology/ Oncology and Stem Cell Therapy

Wolters Kluwer Health · Saudi Arabia · Est. 1998

ISSN2589-0646

SJR Q3✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

Established

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q354

✓ Corroboration (1 more)+6

Total60

Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

181

days submission → published

measured · last 15 articles · accept 156d

weeks to publish · journal-reported

Fast · vs ~15 wk median

SJR Rank

Top 75% in field

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Scorei

0.506

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.704

Total Worksi

814

Total Citationsi

9,151

2yr Mean Citednessi

0.57

Open Impact Factor alternative

Aims & Scope

Subject areas: Hematology; Medicine (miscellaneous); Oncology.

General Information

Country / RegionSaudi Arabia

Primary LanguageEnglish

1st Year Published1998

Annual Volume~ 27 articles / year

StatusActive (last: 2026)

Total Publications814

Publisher OrgElsevier BV

OA Since2007

Visit Journal Website

Submission Info

APC Cost💎 Diamond OA — Free

Peer ReviewDouble-blind

Review Time~8 weeks

Acceptance Rate—

OA LicenseCC BY-NC-SA

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

11/12 · 92%

✅

Do you know the journal / publisher?

Wolters Kluwer Health

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2589-0646

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Double-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

APC fees clearly disclosed?

No APC (Free)

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

380

2019

1.2k

2020

448

2021

2022

123

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

HematologyQ3

Medicine (miscellaneous)Q3

OncologyQ3

Subject Classification

Scopus Categories

HematologyOncologyMedicine (miscellaneous)

Research Topics (OpenAlex)

Hematopoietic Stem Cell TransplantationAcute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentAcute Lymphoblastic Leukemia researchHemoglobinopathies and Related DisordersChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia TreatmentsMultiple Myeloma Research and TreatmentsMyeloproliferative Neoplasms: Diagnosis and TreatmentHuman auditory perception and evaluation

Frequently asked questions about Hematology/ Oncology and Stem Cell Therapy

Is Hematology/ Oncology and Stem Cell Therapy a predatory journal?

PubScope has no integrity flags on record for Hematology/ Oncology and Stem Cell Therapy: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 60/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Hematology/ Oncology and Stem Cell Therapy?

Hematology/ Oncology and Stem Cell Therapy is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.506.

Is Hematology/ Oncology and Stem Cell Therapy indexed in Scopus and Web of Science?

Hematology/ Oncology and Stem Cell Therapy is indexed in Scopus, DOAJ.

What is the aims and scope of Hematology/ Oncology and Stem Cell Therapy?